<SEC-DOCUMENT>0001564590-20-014176.txt : 20200330
<SEC-HEADER>0001564590-20-014176.hdr.sgml : 20200330
<ACCEPTANCE-DATETIME>20200330161059
ACCESSION NUMBER:		0001564590-20-014176
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200327
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200330
DATE AS OF CHANGE:		20200330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IRIDEX CORP
		CENTRAL INDEX KEY:			0001006045
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				770210467
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27598
		FILM NUMBER:		20757104

	BUSINESS ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		6509404700

	MAIL ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>irix-8k_20200327.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
irix-8k_20200327.DOCX.htm
</title>
</head>
<!-- NG Converter v5.0.2.38 -->
<body>

<p style="margin-top:0pt;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:468pt;;">
<tr>
<td style="width:130.5pt;"></td>
<td style="width:0.9pt;"></td>
<td style="width:24.6pt;"></td>
<td style="width:156pt;"></td>
<td style="width:30pt;"></td>
<td style="width:0.9pt;"></td>
<td style="width:125.1pt;"></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;;font-size:16pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.2pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:36pt;;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:16pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.2pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM 8&#8209;K</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:12pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.2pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="7" valign="middle" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:11pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PURSUANT TO SECTION 13 OR 15(d) OF THE<br />SECURITIES EXCHANGE ACT OF 1934</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p></td>
<td colspan="4" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 27, 2020</p></td>
<td colspan="2" valign="top" >
<p style="text-align:left;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Date of Report (date of earliest event reported)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:22pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.2pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">IRIDEX CORPORATION</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="3" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Delaware</p></td>
<td valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">0-27598</p></td>
<td colspan="3" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">77-0210467</p></td>
</tr>
<tr>
<td colspan="3" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of<br />incorporation or organization)</p></td>
<td valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission File Number)</p></td>
<td colspan="3" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer<br />Identification Number)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1212 Terra Bella Avenue<br />Mountain View, California 94043</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, including zip code)</p></td>
</tr>
<tr style="height:20.25pt;">
<td colspan="2" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p></td>
<td colspan="4" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(650) 940-4700</p></td>
<td valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p></td>
</tr>
<tr style="height:11.65pt;">
<td colspan="2" valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;font-weight:bold;">&nbsp;</p></td>
<td colspan="4" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:8pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Registrant&#8217;s telephone number, including area code)</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-weight:bold;">&nbsp;</p></td>
</tr>
<tr style="height:4.5pt;">
<td colspan="7" valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-weight:bold;">&nbsp;</p></td>
</tr>
<tr style="height:11.65pt;">
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:8pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:left;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:normal;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:22.3pt;;margin-right:0.21%;text-indent:-22.3pt;;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="Check1"></a><font style="font-size:10pt;letter-spacing:-0.1pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><a name="Check1"></a>&#9744;</font><font style="font-weight:bold;"></font>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:22.3pt;;margin-right:0.21%;text-indent:-22.3pt;;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;letter-spacing:-0.1pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">&#9744;</font><font style="font-weight:bold;"></font>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:22.3pt;;margin-right:0.21%;text-indent:-22.3pt;;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="Check3"></a><font style="font-size:10pt;letter-spacing:-0.1pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><a name="Check3"></a>&#9744;</font><font style="font-weight:bold;"></font>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:22.3pt;;margin-right:0.21%;text-indent:-22.3pt;;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;letter-spacing:-0.1pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';">&#9744;</font>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.21%;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.21%;text-indent:0pt;;font-size:10pt;letter-spacing:-0.2pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.21%;text-indent:0pt;;font-size:10pt;letter-spacing:0pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&nbsp;&nbsp;<font style="font-size:11pt;font-family:'Times New Roman';">&#9744;</font><font style="font-size:11pt;"></font></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.21%;text-indent:0pt;;font-size:10pt;letter-spacing:0pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;<font style="font-size:11pt;font-family:'Times New Roman';">&#9744;</font><font style="font-size:11pt;"></font></p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  style="width:38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of Class</p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:15%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symbol</p></td>
<td valign="bottom"  style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of Exchange on Which Registered</p></td>
</tr>
<tr>
<td valign="top"  style="width:38%; border-top:solid 0.75pt #000000;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common Stock, par value $0.01 per share</p></td>
<td valign="bottom"  style="width:1%;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:15%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IRIX</p></td>
<td valign="bottom"  style="width:1%;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:45%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nasdaq Global Market</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a>&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.6%;width:104.74%;">
<tr>
<td style="width:10.17%;"></td>
<td style="width:94.57%;"></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 27, 2020, Romeo R. Dizon retired from his position as Vice President of Finance of IRIDEX Corporation (the &#8220;Company&#8221;), effective March 27, 2020.&nbsp;&nbsp;Mr. Dizon did not retire as a result of any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices.&nbsp;&nbsp;In connection with transition matters, Mr. Dizon will be paid approximately $60,000 for continued consulting services.</p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">James Mackaness was appointed by the Company&#8217;s Board of Directors as its Interim Chief Financial Officer on a part-time basis, replacing Mr. Dizon effective March 27, 2020.&nbsp;&nbsp;Mr. Mackaness previously served as the Company&#8217;s Chief Operating Officer from August 2012 to August 2015 and as the Company&#8217;s Chief Financial Officer from January 2008 to August 2012.&nbsp;&nbsp;Mr. Mackaness, age 56 is a partner with FLG Partners, LLC, a leading Silicon Valley chief financial officer services and board advisory consultancy (&#8220;FLG Partners&#8221;) having joined FLG in September 2019. He currently serves part-time as Chief Financial Officer for Soleno Therapeutics, a clinical-stage biopharmaceutical company. Mr. Mackaness previously served as Chief Financial Officer of Invuity, Inc., a medical technology company, from August 2015 until its sale to Stryker Corporation in October 2018, remaining with Styker through January 2019 to complete the integration. From September 2001 to December 2007, Mr. Mackaness served as Chief Financial Officer and Vice President of Finance of NextHop Technologies, Inc., a networking wireless technology company. Prior to that, Mr. Mackaness served as Chief Financial Officer and Vice President of Finance of Infogear Technologies Corporation and began his career with Ernst &amp; Young LLP. </p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with Mr. Mackaness&#8217;s appointment as the Company&#8217;s Interim Chief Financial Officer, the Company entered into a consulting agreement (the &#8220;FLG Consulting Agreement&#8221;) with FLG Partners, LLC. <font style="color:#212529;">Pursuant to the FLG Consulting Agreement, the Company will pay FLG Partners $400 per hour for Mr.&#160;Mackaness&#8217;s services to the Company for actual hours of service provided. The FLG Consulting Agreement with FLG Partners also requires the Company to indemnify Mr.&#160;Mackaness and FLG Partners in connection with the performance of services for the Company. The FLG Consulting Agreement has an indefinite term and is terminable by either party upon 30 days&#8217; advance written notice.</font></p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other than the indemnification described herein, Mr.&#160;Mackaness&#160;has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item&#160;404(a)&#160;of&#160;Regulation&#160;S-K&#160;promulgated under the&#160;Securities Exchange Act of 1934, as amended, nor are any transactions currently proposed.</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are no family relationships between Mr.&#160;Mackaness&#160;and any of the Company&#8217;s directors or executive officers<font style="color:#000000;">.</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01.<font style="font-size:12pt;font-weight:normal;margin-left:36pt;"></font>Financial Statements and Exhibits. </p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.6%;width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr style="height:8.1pt;">
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibits </p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.71%;"></td>
<td style="width:6.7%;"></td>
<td style="width:85.6%;"></td>
</tr>
<tr>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:center;margin-top:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit No.</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="irix-ex991_6.htm"><font style="text-decoration:underline;">Press Release dated March 30, 2020.</font></a></p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:0%;white-space:nowrap">
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">-2</a>-</p></td></tr></table></div>
<hr style="page-break-after:always;width:100%;">
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:7.14%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES </font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:41.65%;">
<tr>
<td style="width:4.06%;"></td>
<td style="width:1.74%;"></td>
<td style="width:35.85%;"></td>
</tr>
<tr>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;text-align:left;">&nbsp;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;text-align:left;">&nbsp;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;text-align:left;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">IRIDEX CORPORATION</p></td>
</tr>
<tr style="height:12pt;">
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:1pt;margin-top:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David I. Bruce</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David I. Bruce</p>
<p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 30, 2020 </p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:0%;white-space:nowrap">
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">-3</a>-</p></td></tr></table></div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>irix-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
irix-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.38 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk14952995"></a><img src="gppsmtdtjokf000001.jpg" title="" alt="" style="width:96px;height:77px;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For Immediate Release</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:14pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">IRIDEX ANNOUNCES RETIREMENT OF VP FINANCE </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Names Prior CFO/COO as Interim CFO </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Mountain View, Calif. March 30, 2020<font style="font-weight:normal;"> -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Romeo Dizon has retired from his position as Vice President of Finance, effective March 27, 2020. Mr. Dizon has agreed to continue to serve as needed as a consultant to facilitate a smooth transition and to provide additional support through the end the Company&#8217;s first quarter 2020 reporting cycle. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IRIDEX&#8217;s Board of Directors has appointed James Mackaness to<font style="color:#FF0000;"> </font><font style="color:#0D0D0D;">serve as interim Chief Financial Officer while it searches for a successor to Mr. Dizon. </font>Mr. Mackaness previously served as IRIDEX&#8217;s Chief Operating Officer from August 2012 to August 2015 and as the Company&#8217;s Chief Financial Officer from January 2008 to August 2012. He is currently a partner with FLG Partners, a leading Silicon Valley CFO services and board advisory consultancy firm, and also currently serves as Chief Financial Officer for Soleno Therapeutics, a clinical-stage biopharmaceutical company. He was previously Chief Financial Officer of Invuity, Inc., a medical technology company, from August 2015 until its sale to Stryker Corporation in October 2018. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;On behalf of everyone at IRIDEX and our Board of Directors, I want to thank Romeo for his many contributions during his 12-year tenure with the Company, including his strong leadership of our financial organization over the past two years,&#8221; said David Bruce, CEO of IRIDEX. &#8220;We appreciate his dedication and wish him all the best beyond IRIDEX.&#8221; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;We are very pleased to welcome Jim Mackaness back to the IRIDEX team. His proven skill set, coupled with in-depth knowledge of our operations and internal processes, provides us great confidence that we will experience seamless continuity in our financial leadership,&#8221; concluded Bruce.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#333333;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">About&#160;IRIDEX</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#333333;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IRIDEX is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company&#8217;s proprietary MicroPulse&#174; technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions.&#160;IRIDEX&#8217;s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in&#160;the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. <font style="color:#000000;">For further information, visit the IRIDEX website at </font><font style="text-decoration:underline;color:#000000;">http://www.iridex.com/</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investor Relations Contact<font style="font-weight:normal;"><br />Leigh Salvo<br />(415) 937-5404<br /></font><font style="text-decoration:underline;font-weight:normal;">investors@iridex.com</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Media Contact<font style="font-weight:normal;"><br />Jamie Hall <br />Pascale Communications, LLC.<br />(724) 417-0167<br /></font><font style="text-decoration:underline;font-weight:normal;">pr@iridex.com</font></p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gppsmtdtjokf000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gppsmtdtjokf000001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "P -P# 2(  A$! Q$!_\0
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MP(RHL".2(A\S$X.3QG[HKDS"IEM/7"3;B_LR6WS.[+*>:5(6QT%&:M[T7O\
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M5?\ A+M_\<H_XBA/^"4'_11/%7'7_BEV_P#CE?S(^#K:#4?%VE6-XBR0S:G
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MI7_*-/\ : _[(SXE_P#39<5_'(?NB@(G]L'[.7_)OG@7_L3=+_\ 22*O(?\
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M_P"(?[4OQG_:6\9Z;=?M/?'/Q=XAL)-2B_M*YO-2>ZD@@+*DKQ1R-L+[!PO
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M' "R*2<'C\VU_P"#RKQ,XY_8&L>O_10G_P#D*OD?]@3]H+Q_^UE_P5B\5?\
M!27X\:'+KO\ PKCPYX@^)VO:99P*\<4&FV,IM+*,N<1*KFVBB<ABK*C')R:
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8]CCQ<LFW]XJ:]:LH;N <#(]\"@GE/__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
